Fully funded for 2 years!
Plus more milestone payments to come in that time.
Plus more licencing deals no doubt.
This could be a cash cow without even needing to actually produce a single drug to market. That will happen no doubt in several years time but even before then it has huge potential for more deals this year imo.
